Ernexa Therapeutics Inc. (ERNAW) Operating income 2016–2025
Ernexa Therapeutics Inc. (ERNAW) annual operating income history from SEC filings — each fiscal year as reported.
-$9.3MFY2025 · since FY2016: -$2.3M → -$9.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.3M | +40.5% |
| FY2024 | -$15.7M | +25.8% |
| FY2023 | -$21.1M | +36.4% |
| FY2022 | -$33.2M | +70.8% |
| FY2021 | -$113.7M | -1469.2% |
| FY2020 | -$7.2M | -311.4% |
| FY2019 | -$1.8M | -968.0% |
| FY2018 | $203,000 | +114.5% |
| FY2017 | -$1.4M | +38.5% |
| FY2016 | -$2.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice